Silvano Ferrini mainly investigates Molecular biology, Immunology, Cancer research, Cytokine and T cell. His Molecular biology research is multidisciplinary, incorporating elements of Cell culture, Antigen, Monocyte, CD3 and T-cell receptor. As part of his studies on Immunology, Silvano Ferrini frequently links adjacent subjects like Cytotoxic T cell.
He has researched Cancer research in several fields, including Carcinogenesis, Cancer stem cell, Stem cell, Genetic enhancement and Tumor progression. His Cytokine study incorporates themes from Chronic lymphocytic leukemia and Cell growth. His T cell research integrates issues from Human leukocyte antigen, CTL*, Cytolysis and Cell biology.
Silvano Ferrini focuses on Cancer research, Molecular biology, Immunology, Antigen and Monoclonal antibody. The Cancer research study combines topics in areas such as Interleukin 12, ALCAM, Pathology, Neuroblastoma and Regulation of gene expression. His Molecular biology research includes themes of Cell culture, T cell, T-cell receptor, Lymphokine and CD3.
His Cytokine, Immunotherapy, Immune system, Interleukin 15 and Interleukin 21 investigations are all subjects of Immunology research. He has included themes like Signal transduction and In vivo in his Cytokine study. His biological study deals with issues like Interleukin 2, which deal with fields such as Cytolysis.
Cancer research, Immunology, Cytokine, Immunotherapy and Neuroblastoma are his primary areas of study. Silvano Ferrini works in the field of Cancer research, focusing on Melanoma in particular. The concepts of his Cytokine study are interwoven with issues in Human leukocyte antigen and Signal transduction.
His biological study spans a wide range of topics, including Cytotoxic T cell, Monoclonal antibody and T cell. In his work, Molecular biology is strongly intertwined with SOCS3, which is a subfield of Interleukin 27. As a part of the same scientific study, Silvano Ferrini usually deals with the Molecular biology, concentrating on Carcinogenesis and frequently concerns with microRNA.
Silvano Ferrini mainly investigates Cancer research, Immunology, Cancer immunotherapy, Cancer and Immunotherapy. His biological study focuses on Melanoma. Silvano Ferrini studies Immunology, focusing on Immune checkpoint in particular.
His research in Cancer immunotherapy intersects with topics in Natural killer T cell, Lymphokine-activated killer cell and Interleukin 15. His studies deal with areas such as Monoclonal antibody, Treatment failure, Immune system and Drug resistance as well as Cancer. His Immunotherapy study deals with Cytokine intersecting with Glycoprotein 130, Cytotoxic T cell and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CIITA-Induced MHC Class II Expression in Mammary Adenocarcinoma Leads to a Th1 Polarization of the Tumor Microenvironment, Tumor Rejection, and Specific Antitumor Memory
Lorenzo Mortara;Patrizia Castellani;Raffaella Meazza;Giovanna Tosi.
Clinical Cancer Research (2006)
HIV-1 Tat protein mimicry of chemokines
Adriana Albini;Silvano Ferrini;Roberto Benelli;Sabrina Sforzini.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix
Barbara Carnemolla;Laura Borsi;Enrica Balza;Patrizia Castellani.
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production
Maria Cristina Mingari;Chiara Vitale;Anna Cambiaggi;Francesca Schiavetti.
International Immunology (1995)
Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.
Cristina Bottino;Giuseppe Tambussi;Silvano Ferrini;Ermanno Ciccone.
Journal of Experimental Medicine (1988)
IL-21 Induces Tumor Rejection by Specific CTL and IFN-γ-Dependent CXC Chemokines in Syngeneic Mice
Emma Di Carlo;Alberto Comes;Anna Maria Orengo;Ombretta Rosso.
Journal of Immunology (2004)
IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer
Rita Rotondo;Gaia Barisione;Luca Mastracci;Francesco Grossi.
International Journal of Cancer (2009)
Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance.
Rosaria Gangemi;Laura Paleari;Anna Maria Orengo;Alfredo Cesario.
Current Medicinal Chemistry (2009)
T cell clones expressing the natural killer cell‐related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function
Silvano Ferrini;Anna Cambiaggi;Raffaella Meazza;Sabrina Sforzini.
European Journal of Immunology (1994)
Interleukin-15 (IL-15) Induces NF-κB Activation and IL-8 Production in Human Neutrophils
Patrick P. McDonald;Maria Pia Russo;Silvano Ferrini;Marco A. Cassatella.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: